Scientific publications

Nature Communications, 2026

AI-based multiomics profiling reveals complementary omics contributions to personalized prediction of cardiovascular disease

Luo Y., Zhang N., Yang J. et al.

Cancer Science, 2026

Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With Atezolizumab

Mouri A., Kagamu H., Tamada K. et al.

Investigative Ophthalmology & Visual Science, 2026

Large-Scaled Proteomics Analysis for Glaucoma: Integrated Genetics, Multi-Omics, UK Biobank and Therapeutic Analysis

Xu J., Gao Y., Yu J. et al.

Cardiovascular Diabetology, 2026

Clinical subgroup-stratified plasma proteomic signatures improve risk prediction for myocardial infarction: SCORE2-Pro

Tong M., Zhang M., Xu M. et al.

Research, 2026

Repurposed Acarbose Targets Nidogen-1 to Remodel the Tumor Stroma and Suppress Portal Vein Tumor Thrombus in Hepatocellular Carcinoma

Han T., Chen L., Liu N. et al.

Research, 2026

Repurposed Acarbose Targets Nidogen-1 to Remodel the Tumor Stroma and Suppress Portal Vein Tumor Thrombus in Hepatocellular Carcinoma

Han T., Chen L., Liu N. et al.

ACR Open Rheumatology, 2026

Macrophage Activation Syndrome–Associated Proteins and Enhanced Interferon‐γ Responsiveness in the Plasma Proteome of Patients With Multisystem Inflammatory Syndrome in Children in a Pretreatment Replication Single‐Center Cohort

McCuaig S., Toland C., Konvinse K. et al.

Mediators of Inflammation, 2026

Convergent Multistage Evidence Implicates the CCR2–Artemin Immune–Inflammation Axis in Acute Myeloid Leukemia

Jin Y., Lu H., Yu X. et al.

Mediators of Inflammation, 2026

Identification of Treatment Targets in Allergic Conjunctivitis Through Proteome‐Scale Mendelian Randomization Analysis

Li H., Zhang Y., Shang Y. et al.

BMC Medicine, 2026

CardioMetAge estimates cardiometabolic aging and predicts disease outcomes

Li Y., Xu X., Zheng Y. et al.

Journal of Neurosurgery: Pediatrics, 2026

Cell division cycle 42 binding protein beta as a plasma-based biomarker for cerebral cavernous malformations

Hattar Y., Sesen J., Martinez T. et al.

iScience, 2026

Persistent viral control status is associated with enhanced innate immune responses in people with HIV-1

C. dos Santos J., Groenendijk A., Ruijten S. et al.

International Journal of Biological Macromolecules, 2026

A role of FURIN in promoting TGF-β signaling activation in MAFLD: Evidence from UK Biobank proteomic cohort

Wang H., Li X., Xu X. et al.

Journal of Translational Medicine, 2026

Machine learning-based clinical prediction model and multi-omics integration for assessing pancreatic cancer risk in new-onset diabetes

Yang J., Cao B., Yuemaierabola A. et al.

Journal for ImmunoTherapy of Cancer, 2026

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma

O’Reilly E., Cabanski C., Lyman J. et al.

Hypertension, 2026

Galectin-1 Is a Marker but Not a Mediator of Heart Failure With Preserved Ejection Fraction

Wassenaar J., Smart C., Fehrenbach D. et al.

Diabetologia, 2026

Adrenaline is a prominent driver of inflammatory responses following hypoglycaemia

Mustafajev I., Hendriksz M., Stienstra R. et al.

Blood Immunology & Cellular Therapy, 2026

Identification of a plasma immune marker panel for early detection of acute graft-versus-host disease in children

Klein Lebbink W., de Koning C., Kunstek H. et al.

Reviews in Cardiovascular Medicine, 2026

Olink Proteomics in Heart Failure: A Comprehensive Review of Applications From Biomarker Discovery to Pathophysiological Insights and Clinical Implementation

Zheng Z., Gong Z., Gu J.

Resuscitation, 2026

Large-scale plasma proteomic analysis identifies pathophysiological mechanisms and predictive biomarkers for cardiac arrest

Wang N., Guo Y., Lu S. et al.